![The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): development of clinical cut-off scores Abstract The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): development of clinical cut-off scores Abstract](https://s2.studylib.net/store/data/012455520_1-b5516724e2a94375f40a5f4a8c86473a-768x994.png)
The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): development of clinical cut-off scores Abstract
![Clinical evaluation of the effects of cutting off, overlapping, and rescanning procedures on intraoral scanning accuracy - Journal of Prosthetic Dentistry Clinical evaluation of the effects of cutting off, overlapping, and rescanning procedures on intraoral scanning accuracy - Journal of Prosthetic Dentistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7ceb587d-3222-44e1-81d6-e20f80a790f4/gr1_lrg.jpg)
Clinical evaluation of the effects of cutting off, overlapping, and rescanning procedures on intraoral scanning accuracy - Journal of Prosthetic Dentistry
![Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response ... Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2017.402/MediaObjects/41416_2018_Article_BFbjc2017402_Fig2_HTML.jpg)
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response ...
![Defining Lower (L) and Upper (U) Phenotypic Clinical Cutoffs (CCO's) for Tipranavir/r (TPV), Lopinavir/r (LPV), Saquinavir (SQV) and Amprenavir (APV) Co-Administered with Ritonavir (r) Within the RESIST Dataset by the PhenoSense Assay Defining Lower (L) and Upper (U) Phenotypic Clinical Cutoffs (CCO's) for Tipranavir/r (TPV), Lopinavir/r (LPV), Saquinavir (SQV) and Amprenavir (APV) Co-Administered with Ritonavir (r) Within the RESIST Dataset by the PhenoSense Assay](https://www.natap.org/2006/images/101206/upperClinical-3.gif)
Defining Lower (L) and Upper (U) Phenotypic Clinical Cutoffs (CCO's) for Tipranavir/r (TPV), Lopinavir/r (LPV), Saquinavir (SQV) and Amprenavir (APV) Co-Administered with Ritonavir (r) Within the RESIST Dataset by the PhenoSense Assay
![Overview on determination of ECOFF, PK/PD breakpoints ,clinical cut-offs and the setting of Clinical breakpoint by VetCAST VMAS symposium/workshop Uppsala. - ppt download Overview on determination of ECOFF, PK/PD breakpoints ,clinical cut-offs and the setting of Clinical breakpoint by VetCAST VMAS symposium/workshop Uppsala. - ppt download](https://slideplayer.com/slide/14341200/89/images/9/Definitions+ECOFF+Clinical+cut-off.jpg)
Overview on determination of ECOFF, PK/PD breakpoints ,clinical cut-offs and the setting of Clinical breakpoint by VetCAST VMAS symposium/workshop Uppsala. - ppt download
![Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis | The BMJ Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis | The BMJ](https://www.bmj.com/content/bmj/346/bmj.f2492/F1.large.jpg)
Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis | The BMJ
![A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer](https://data08.123doks.com/thumbv2/123dokorg/000/242/242552/cover.webp)
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer
![Chemosensors | Free Full-Text | The Challenges of Developing Biosensors for Clinical Assessment: A Review | HTML Chemosensors | Free Full-Text | The Challenges of Developing Biosensors for Clinical Assessment: A Review | HTML](https://www.mdpi.com/chemosensors/chemosensors-09-00299/article_deploy/html/images/chemosensors-09-00299-g011-550.jpg)
Chemosensors | Free Full-Text | The Challenges of Developing Biosensors for Clinical Assessment: A Review | HTML
![Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice - Multiple Sclerosis and Related Disorders Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/de019777-11db-46a4-ad7d-a741e3dd37d9/gr1_lrg.jpg)
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice - Multiple Sclerosis and Related Disorders
![Determining a cutoff score for the family burden interview schedule using three statistical methods | BMC Medical Research Methodology | Full Text Determining a cutoff score for the family burden interview schedule using three statistical methods | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-019-0734-8/MediaObjects/12874_2019_734_Fig1_HTML.png)
Determining a cutoff score for the family burden interview schedule using three statistical methods | BMC Medical Research Methodology | Full Text
![Cut-off Scores and Clinical Change Indices for the Dutch Outcome Questionnaire (OQ-45) in a Large Sample of Normal and Several Psychotherapeutic Populations. | Semantic Scholar Cut-off Scores and Clinical Change Indices for the Dutch Outcome Questionnaire (OQ-45) in a Large Sample of Normal and Several Psychotherapeutic Populations. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6efe700ff73ae7a238325ab66310f9d43f8dea8/7-Table3-1.png)
Cut-off Scores and Clinical Change Indices for the Dutch Outcome Questionnaire (OQ-45) in a Large Sample of Normal and Several Psychotherapeutic Populations. | Semantic Scholar
![Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a4832396-2f9b-49ff-9fb2-3887a4075486/gr1.jpg)
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity - eBioMedicine
Virta Health on Twitter: "New research alert: Virta patients improve depressive symptoms, many seeing notable change in the first 10 wks. At 2 yrs, nearly one-third no longer met clinical cut-off for
Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients | PLOS ONE
![Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper - ScienceDirect Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177920300202-fx1.jpg)
Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper - ScienceDirect
![The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma – What Cut-off Values Should We Use? - Clinical Oncology The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma – What Cut-off Values Should We Use? - Clinical Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ce7f749e-9d47-4481-9f8d-137138858398/gr1_lrg.jpg)
The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma – What Cut-off Values Should We Use? - Clinical Oncology
![ANALYSES OF SUSCEPTIBILITY AND CROSS-RESISTANCE BETWEEN TMC114 AND OTHER PROTEASE INHIBITORS AMONG >56,000 ROUTINE SAMPLES, USING LINEAR REGRESSION MODEL-BASED FOLD CHANGE PREDICTIONS ANALYSES OF SUSCEPTIBILITY AND CROSS-RESISTANCE BETWEEN TMC114 AND OTHER PROTEASE INHIBITORS AMONG >56,000 ROUTINE SAMPLES, USING LINEAR REGRESSION MODEL-BASED FOLD CHANGE PREDICTIONS](https://www.natap.org/2006/images/062706/virco-1.gif)
ANALYSES OF SUSCEPTIBILITY AND CROSS-RESISTANCE BETWEEN TMC114 AND OTHER PROTEASE INHIBITORS AMONG >56,000 ROUTINE SAMPLES, USING LINEAR REGRESSION MODEL-BASED FOLD CHANGE PREDICTIONS
![Covaxin: Bharat Biotech aims to improve clinical results by at least 60%, above regulator cut-off mark | India News,The Indian Express Covaxin: Bharat Biotech aims to improve clinical results by at least 60%, above regulator cut-off mark | India News,The Indian Express](https://images.indianexpress.com/2020/10/covaxin-2.jpg)